Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
2seventy bio
Biotech
Regeneron to fill gaps in obesity, break ground in cell therapy
Regeneron wants to improve on obesity care with a muscle-preservation approach, while elsewhere, the biopharma charts a new course in cell therapy.
Annalee Armstrong
Feb 2, 2024 10:25am
Ex-Eisai leader to be new NextPoint CEO—Chutes & Ladders
Feb 2, 2024 9:30am
2seventy splits again, sending cell therapy R&D to Regeneron
Jan 30, 2024 1:30pm
2seventy axes 40% of roles, changes CEO as cell therapy falters
Sep 12, 2023 8:58am
FDA puts 2seventy CAR-T trial on hold in wake of patient death
Aug 14, 2023 9:20am
Death triggers pause of 2seventy CAR-T cell therapy AML trial
Jun 14, 2023 8:30am